TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis
Conditions
Multiple Sclerosis, Relapsing-Remitting
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
CHU de Besançon, Besançon, France
Contact: Principal Investigator (Eric BERGER, MD)Johann BARKATZ, MD (Sub-investigator)CHU Nancy, Nancy, France
Contact: Principal Investigator (Guillaume MATHEY, MD)Pierre LECOANET, MD (Sub-investigator)Hôpital Pitié-Salpêtrière, Paris, France
Contact: Principal Investigator (Céline Dr LOUAPRE, Dr)CHU de Rennes/Pontchaillou, Rennes, France
Contact: Principal Investigator (Laure MICHEL, MD)Anne KERBRAT, MD (Sub-investigator)Andrea MANUNTA, MD (Sub-investigator)CHRU de Strasbourg, Strasbourg, France
Contact: Study coordinator (Laurent D KREMER, MD) · laurentdaniel.kremer@chru-strasbourg.fr · +333 88 12 87 33Contact: Study coordinator (Nicolas COLLONGUES, MD) · nicolas.collongues@chru-strasbourg.fr · +333 88 12 87 33Nicolas COLLONGUES, MD (Sub-investigator)Jérôme DE SEZE, MD (Sub-investigator)Thibault TRICARD, MD (Sub-investigator)Marie Céline FLEURY, MD (Sub-investigator)Livia LANOTTE, MD (Sub-investigator)
Study leads
Laurent D KREMER, MD
Principal Investigator
CHU Strasbourg